{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T11:13:13Z","timestamp":1783077193532,"version":"3.54.6"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100005825","name":"USDA National Institute of Food and Agriculture","doi-asserted-by":"crossref","award":["2020-67015-31470"],"award-info":[{"award-number":["2020-67015-31470"]}],"id":[{"id":"10.13039\/100005825","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virus Genes"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Marek\u2019s disease (MD) is caused by the highly contagious Marek\u2019s disease virus (MDV), a tumorigenic alphaherpesvirus. The disease is presently managed through vaccination. Nevertheless, the dynamic nature of MDV presents challenges, as new virulent strains may arise that can potentially overcome existing vaccine-mediated immunity. To address this, new and more effective vaccines are crucial. The immune system\u2019s first line of defense against infections is the innate immune response, where type I interferons (IFN-I) play a key role. As with other alphaherpesviruses, MDV encodes numerous genes capable of modulating IFN-I production during infection. Ablation of these genes in MDV could result in attenuation, thereby facilitating the creation of novel vaccine strains with augmented IFN-I induction during infection. Hence, a system to identify immunomodulatory MDV gene products that impede IFN-I production in avian innate immune cells is required. Herein, we present an innovative screening method that quantifies the expression of Interferon Omega 1 (IFN\u03c91) in an avian macrophage-like cell line expressing MDV genes via recombinant lentivirus (rLV) integration. Five MDV gene products hypothesized to inhibit IFN-I production (Meq, US3, R-LORF4, UL46, and UL48) were assayed in our screening system. Stable expression of all MDV genes was obtained when rLV was utilized to insert these genes into HD11 cells. Additionally, we established the optimal conditions for activation of the IFN-I response in HD11 cells using a 2\u00a0kb double-stranded DNA segment delivered by transfection as a stimulant. With this approach, we demonstrated that these MDV gene products significantly decreased the gene expression of IFN-I when activated by transfection with double-stranded DNA.<\/jats:p>","DOI":"10.1007\/s11262-026-02224-z","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T07:27:40Z","timestamp":1774596460000},"page":"318-327","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The use of an avian macrophage-like cell line (HD11) transduced with recombinant lentiviruses to dissect the immunomodulatory role of Marek\u2019s disease virus gene products"],"prefix":"10.1007","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5353-2081","authenticated-orcid":false,"given":"Sonsiray","family":"Alvarez-Narvaez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6752-8147","authenticated-orcid":false,"given":"Steven J.","family":"Conrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5699-998X","authenticated-orcid":false,"given":"Taejoong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1545-5855","authenticated-orcid":false,"given":"Stephen","family":"Spatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7287-0916","authenticated-orcid":false,"given":"John R.","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,27]]},"reference":[{"key":"2224_CR1","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1637\/11525-110216-Reg.1","volume":"61","author":"DA Kennedy","year":"2017","unstructured":"Kennedy DA et al (2017) Industry-wide surveillance of Marek\u2019s disease virus on commercial poultry farms. Avian Dis 61:153\u2013164. https:\/\/doi.org\/10.1637\/11525-110216-Reg.1","journal-title":"Avian Dis"},{"key":"2224_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/ani12050540","author":"B Song","year":"2022","unstructured":"Song B et al (2022) A review on the Marek\u2019s disease outbreak and its virulence-related meq genovariation in Asia between 2011 and 2021. Animals (Basel). https:\/\/doi.org\/10.3390\/ani12050540","journal-title":"Animals (Basel)"},{"key":"2224_CR3","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.epidem.2019.01.004","volume":"27","author":"C Rozins","year":"2019","unstructured":"Rozins C, Day T, Greenhalgh S (2019) Managing Marek\u2019s disease in the egg industry. Epidemics 27:52\u201358. https:\/\/doi.org\/10.1016\/j.epidem.2019.01.004","journal-title":"Epidemics"},{"key":"2224_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12030647","author":"LD Bertzbach","year":"2020","unstructured":"Bertzbach LD, Conradie AM, You Y, Kaufer BB (2020) Latest insights into Marek\u2019s disease virus pathogenesis and tumorigenesis. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers12030647","journal-title":"Cancers (Basel)"},{"key":"2224_CR5","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/B978-012088379-0\/50009-8","volume-title":"Marek\u2019s disease","author":"C Morrow","year":"2004","unstructured":"Morrow C, Fehler F (2004) Marek\u2019s disease. In: Davison F, Nair V (eds) Marek\u2019s disease. Academic Press, pp 49\u201361"},{"key":"2224_CR6","doi-asserted-by":"publisher","first-page":"413","DOI":"10.2307\/1588488","volume":"14","author":"W Okazaki","year":"1970","unstructured":"Okazaki W, Purchase HG, Burmester BR (1970) Protection against Marek\u2019s disease by vaccination with a herpesvirus of turkeys. Avian Dis 14:413\u2013429","journal-title":"Avian Dis"},{"key":"2224_CR7","doi-asserted-by":"publisher","first-page":"525","DOI":"10.2460\/ajvr.1970.31.03.525","volume":"31","author":"RL Witter","year":"1970","unstructured":"Witter RL, Nazerian K, Purchase HG, Burgoyne GH (1970) Isolation from turkeys of a cell-associated herpesvirus antigenically related to Marek\u2019s disease virus. Am J Vet Res 31:525\u2013538","journal-title":"Am J Vet Res"},{"key":"2224_CR8","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.vetmic.2016.11.024","volume":"206","author":"SM Reddy","year":"2017","unstructured":"Reddy SM, Izumiya Y, Lupiani B (2017) Marek\u2019s disease vaccines: current status, and strategies for improvement and development of vector vaccines. Vet Microbiol 206:113\u2013120. https:\/\/doi.org\/10.1016\/j.vetmic.2016.11.024","journal-title":"Vet Microbiol"},{"key":"2224_CR9","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1637\/10341-083112-Reg.1","volume":"57","author":"T Islam","year":"2013","unstructured":"Islam T, Renz KG, Walkden-Brown SW, Ralapanawe S (2013) Viral kinetics, shedding profile, and transmission of serotype 1 Marek\u2019s disease vaccine Rispens\/CVI988 in maternal antibody-free chickens. Avian Dis 57:454\u2013463. https:\/\/doi.org\/10.1637\/10341-083112-Reg.1","journal-title":"Avian Dis"},{"key":"2224_CR10","doi-asserted-by":"publisher","first-page":"e3000619","DOI":"10.1371\/journal.pbio.3000619","volume":"18","author":"RI Bailey","year":"2020","unstructured":"Bailey RI et al (2020) Pathogen transmission from vaccinated hosts can cause dose-dependent reduction in virulence. PLoS Biol 18:e3000619. https:\/\/doi.org\/10.1371\/journal.pbio.3000619","journal-title":"PLoS Biol"},{"key":"2224_CR11","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.vetimm.2006.03.014","volume":"112","author":"SJ Baigent","year":"2006","unstructured":"Baigent SJ, Smith LP, Nair VK, Currie RJ (2006) Vaccinal control of Marek\u2019s disease: current challenges, and future strategies to maximize protection. Vet Immunol Immunopathol 112:78\u201386. https:\/\/doi.org\/10.1016\/j.vetimm.2006.03.014","journal-title":"Vet Immunol Immunopathol"},{"key":"2224_CR12","doi-asserted-by":"publisher","first-page":"C31","DOI":"10.1016\/j.vaccine.2008.04.009","volume":"26","author":"IM Gimeno","year":"2008","unstructured":"Gimeno IM (2008) Marek\u2019s disease vaccines: a solution for today but a worry for tomorrow? Vaccine 26:C31\u2013C41. https:\/\/doi.org\/10.1016\/j.vaccine.2008.04.009","journal-title":"Vaccine"},{"key":"2224_CR13","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1093\/emph\/eoac015","volume":"10","author":"JJ Bull","year":"2022","unstructured":"Bull JJ, Antia R (2022) Which \u2018imperfect vaccines\u2019 encourage the evolution of higher virulence? Evol Med Public Health 10:202\u2013213. https:\/\/doi.org\/10.1093\/emph\/eoac015","journal-title":"Evol Med Public Health"},{"key":"2224_CR14","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1111\/j.1558-5646.2012.01803.x","volume":"67","author":"KE Atkins","year":"2013","unstructured":"Atkins KE et al (2013) Vaccination and reduced cohort duration can drive virulence evolution: Marek\u2019s disease virus and industrialized agriculture. Evolution 67:851\u2013860. https:\/\/doi.org\/10.1111\/j.1558-5646.2012.01803.x","journal-title":"Evolution"},{"key":"2224_CR15","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s00285-016-0973-9","volume":"73","author":"C Rozins","year":"2016","unstructured":"Rozins C, Day T (2016) Disease eradication on large industrial farms. J Math Biol 73:885\u2013902. https:\/\/doi.org\/10.1007\/s00285-016-0973-9","journal-title":"J Math Biol"},{"key":"2224_CR16","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/eva.12442","volume":"10","author":"C Rozins","year":"2017","unstructured":"Rozins C, Day T (2017) The industrialization of farming may be driving virulence evolution. Evol Appl 10:189\u2013198. https:\/\/doi.org\/10.1111\/eva.12442","journal-title":"Evol Appl"},{"key":"2224_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/v15071434","author":"JL Liu","year":"2023","unstructured":"Liu JL et al (2023) Emerging hypervirulent Marek\u2019s disease virus variants significantly overcome protection conferred by commercial vaccines. Viruses. https:\/\/doi.org\/10.3390\/v15071434","journal-title":"Viruses"},{"key":"2224_CR18","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00047-18","author":"J Tian","year":"2018","unstructured":"Tian J et al (2018) Feline herpesvirus 1 US3 blocks the type I interferon signal pathway by targeting interferon regulatory factor 3 dimerization in a kinase-independent manner. J Virol. https:\/\/doi.org\/10.1128\/JVI.00047-18","journal-title":"J Virol"},{"key":"2224_CR19","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.virol.2009.01.001","volume":"386","author":"KM Rogers","year":"2009","unstructured":"Rogers KM et al (2009) Type I IFN response to Papiine herpesvirus 2 (Herpesvirus papio 2; HVP2) determines neuropathogenicity in mice. Virology 386:280\u2013289. https:\/\/doi.org\/10.1016\/j.virol.2009.01.001","journal-title":"Virology"},{"key":"2224_CR20","doi-asserted-by":"publisher","first-page":"41461","DOI":"10.1038\/srep41461","volume":"7","author":"Y Ma","year":"2017","unstructured":"Ma Y et al (2017) An engineered herpesvirus activates dendritic cells and induces protective immunity. Sci Rep 7:41461. https:\/\/doi.org\/10.1038\/srep41461","journal-title":"Sci Rep"},{"key":"2224_CR21","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/nri3787","volume":"15","author":"F McNab","year":"2015","unstructured":"McNab F, Mayer-Barber K, Sher A, Wack A, O\u2019Garra A (2015) Type I interferons in infectious disease. Nat Rev Immunol 15:87\u2013103. https:\/\/doi.org\/10.1038\/nri3787","journal-title":"Nat Rev Immunol"},{"key":"2224_CR22","doi-asserted-by":"publisher","first-page":"e0181823","DOI":"10.1128\/mbio.01818-23","volume":"14","author":"K Danastas","year":"2023","unstructured":"Danastas K et al (2023) Interferon inhibits the release of herpes simplex virus-1 from the axons of sensory neurons. MBio 14:e0181823. https:\/\/doi.org\/10.1128\/mbio.01818-23","journal-title":"MBio"},{"key":"2224_CR23","doi-asserted-by":"publisher","first-page":"8411","DOI":"10.1128\/jvi.78.16.8411-8420.2004","volume":"78","author":"GT Melroe","year":"2004","unstructured":"Melroe GT, DeLuca NA, Knipe DM (2004) Herpes Simplex Virus 1 has multiple mechanisms for blocking virus-induced interferon production. J Virol 78:8411\u20138420. https:\/\/doi.org\/10.1128\/jvi.78.16.8411-8420.2004","journal-title":"J Virol"},{"key":"2224_CR24","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nri2937","volume":"11","author":"SR Paludan","year":"2011","unstructured":"Paludan SR, Bowie AG, Horan KA, Fitzgerald KA (2011) Recognition of herpesviruses by the innate immune system. Nat Rev Immunol 11:143\u2013154. https:\/\/doi.org\/10.1038\/nri2937","journal-title":"Nat Rev Immunol"},{"key":"2224_CR25","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.vetimm.2019.04.010","volume":"212","author":"GR Sun","year":"2019","unstructured":"Sun GR et al (2019) Differential expression of type I interferon mRNA and protein levels induced by virulent Marek\u2019s disease virus infection in chickens. Vet Immunol Immunopathol 212:15\u201322. https:\/\/doi.org\/10.1016\/j.vetimm.2019.04.010","journal-title":"Vet Immunol Immunopathol"},{"key":"2224_CR26","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01934-18","author":"L Gao","year":"2019","unstructured":"Gao L et al (2019) Inhibition of DNA-sensing pathway by Marek\u2019s Disease Virus VP23 protein through suppression of interferon regulatory factor 7 activation. J Virol. https:\/\/doi.org\/10.1128\/JVI.01934-18","journal-title":"J Virol"},{"key":"2224_CR27","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01037-19","author":"Y Liu","year":"2019","unstructured":"Liu Y et al (2019) Marek\u2019s disease virus RLORF4 inhibits type I interferon production by antagonizing NF-kappaB activation. J Virol. https:\/\/doi.org\/10.1128\/JVI.01037-19","journal-title":"J Virol"},{"key":"2224_CR28","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/s41541-024-00905-0","volume":"9","author":"ZJ Zhu","year":"2024","unstructured":"Zhu ZJ et al (2024) Immune escape of avian oncogenic Marek\u2019s disease herpesvirus and antagonistic host immune responses. NPJ Vaccines 9:109. https:\/\/doi.org\/10.1038\/s41541-024-00905-0","journal-title":"NPJ Vaccines"},{"key":"2224_CR29","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00892-20","author":"Y Liao","year":"2020","unstructured":"Liao Y et al (2020) Role of Marek\u2019s disease virus (MDV)-encoded US3 serine\/threonine protein kinase in regulating MDV Meq and cellular CREB phosphorylation. J Virol. https:\/\/doi.org\/10.1128\/jvi.00892-20","journal-title":"J Virol"},{"key":"2224_CR30","doi-asserted-by":"publisher","first-page":"e1007999","DOI":"10.1371\/journal.ppat.1007999","volume":"15","author":"K Li","year":"2019","unstructured":"Li K et al (2019) Avian oncogenic herpesvirus antagonizes the cGAS-STING DNA-sensing pathway to mediate immune evasion. PLoS Pathog 15:e1007999. https:\/\/doi.org\/10.1371\/journal.ppat.1007999","journal-title":"PLoS Pathog"},{"key":"2224_CR31","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/0092-8674(79)90057-6","volume":"18","author":"H Beug","year":"1979","unstructured":"Beug H, von Kirchbach A, D\u00f6derlein G, Conscience J-F, Graf T (1979) Chicken hematopoietic cells transformed by seven strains of defective avian leukemia viruses display three distinct phenotypes of differentiation. Cell 18:375\u2013390. https:\/\/doi.org\/10.1016\/0092-8674(79)90057-6","journal-title":"Cell"},{"key":"2224_CR32","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41541-020-00251-x","volume":"5","author":"G Brar","year":"2020","unstructured":"Brar G et al (2020) Deletion of immune evasion genes provides an effective vaccine design for tumor-associated herpesviruses. NPJ Vaccines 5:102. https:\/\/doi.org\/10.1038\/s41541-020-00251-x","journal-title":"NPJ Vaccines"},{"key":"2224_CR33","doi-asserted-by":"publisher","first-page":"5477","DOI":"10.1073\/pnas.0801295105","volume":"105","author":"Z Wang","year":"2008","unstructured":"Wang Z et al (2008) Regulation of innate immune responses by DAI (DLM-1\/ZBP1) and other DNA-sensing molecules. Proc Natl Acad Sci U S A 105:5477\u20135482. https:\/\/doi.org\/10.1073\/pnas.0801295105","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2224_CR34","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.3389\/fimmu.2020.01487","volume":"11","author":"L Wang","year":"2020","unstructured":"Wang L et al (2020) AIM2 inflammasome\u2019s first decade of discovery: focus on oral diseases. Front Immunol 11:1487. https:\/\/doi.org\/10.3389\/fimmu.2020.01487","journal-title":"Front Immunol"},{"key":"2224_CR35","doi-asserted-by":"publisher","first-page":"931885","DOI":"10.3389\/fimmu.2022.931885","volume":"13","author":"L Deng","year":"2022","unstructured":"Deng L et al (2022) Insights on the cGAS-STING signaling pathway during Herpesvirus infections. Front Immunol 13:931885. https:\/\/doi.org\/10.3389\/fimmu.2022.931885","journal-title":"Front Immunol"},{"key":"2224_CR36","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1126\/science.1232458","volume":"339","author":"L Sun","year":"2013","unstructured":"Sun L, Wu J, Du F, Chen X, Chen ZJ (2013) Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 339:786\u2013791. https:\/\/doi.org\/10.1126\/science.1232458","journal-title":"Science"},{"key":"2224_CR37","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/ni.3267","volume":"16","author":"AM Herzner","year":"2015","unstructured":"Herzner AM et al (2015) Sequence-specific activation of the DNA sensor cGAS by Y-form DNA structures as found in primary HIV-1 cDNA. Nat Immunol 16:1025\u20131033. https:\/\/doi.org\/10.1038\/ni.3267","journal-title":"Nat Immunol"},{"key":"2224_CR38","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nature07317","volume":"455","author":"H Ishikawa","year":"2008","unstructured":"Ishikawa H, Barber GN (2008) STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 455:674\u2013678. https:\/\/doi.org\/10.1038\/nature07317","journal-title":"Nature"},{"key":"2224_CR39","doi-asserted-by":"publisher","first-page":"eaax3333","DOI":"10.1126\/sciadv.aax3333","volume":"6","author":"J Guerra","year":"2020","unstructured":"Guerra J et al (2020) Lysyl-tRNA synthetase produces diadenosine tetraphosphate to curb STING-dependent inflammation. Sci Adv 6:eaax3333. https:\/\/doi.org\/10.1126\/sciadv.aax3333","journal-title":"Sci Adv"},{"key":"2224_CR40","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/nrmicro1382","volume":"4","author":"N Osterrieder","year":"2006","unstructured":"Osterrieder N, Kamil JP, Schumacher D, Tischer BK, Trapp S (2006) Marek\u2019s disease virus: from miasma to model. Nat Rev Microbiol 4:283\u2013294. https:\/\/doi.org\/10.1038\/nrmicro1382","journal-title":"Nat Rev Microbiol"},{"key":"2224_CR41","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.4049\/jimmunol.1202749","volume":"190","author":"KA Horan","year":"2013","unstructured":"Horan KA et al (2013) Proteasomal degradation of herpes simplex virus capsids in macrophages releases DNA to the cytosol for recognition by DNA sensors. J Immunol 190:2311\u20132319. https:\/\/doi.org\/10.4049\/jimmunol.1202749","journal-title":"J Immunol"},{"key":"2224_CR42","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/nature12305","volume":"498","author":"F Civril","year":"2013","unstructured":"Civril F et al (2013) Structural mechanism of cytosolic DNA sensing by cGAS. Nature 498:332\u2013337. https:\/\/doi.org\/10.1038\/nature12305","journal-title":"Nature"},{"key":"2224_CR43","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.15252\/embr.201744017","volume":"18","author":"S Luecke","year":"2017","unstructured":"Luecke S et al (2017) cGAS is activated by DNA in a length-dependent manner. EMBO Rep 18:1707\u20131715. https:\/\/doi.org\/10.15252\/embr.201744017","journal-title":"EMBO Rep"},{"key":"2224_CR44","doi-asserted-by":"publisher","first-page":"101384","DOI":"10.1016\/j.xpro.2022.101384","volume":"3","author":"H Chamma","year":"2022","unstructured":"Chamma H, Guha S, Laguette N, Vila IK (2022) Protocol to induce and assess cGAS-STING pathway activation in vitro. STAR Protoc 3:101384. https:\/\/doi.org\/10.1016\/j.xpro.2022.101384","journal-title":"STAR Protoc"},{"key":"2224_CR45","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.cmet.2021.12.007","volume":"34","author":"IK Vila","year":"2022","unstructured":"Vila IK et al (2022) STING orchestrates the crosstalk between polyunsaturated fatty acid metabolism and inflammatory responses. Cell Metab 34:125-139.e128. https:\/\/doi.org\/10.1016\/j.cmet.2021.12.007","journal-title":"Cell Metab"},{"key":"2224_CR46","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1006\/mthe.2000.0083","volume":"1","author":"T Kafri","year":"2000","unstructured":"Kafri T, van Praag H, Gage FH, Verma IM (2000) Lentiviral vectors: regulated gene expression. Mol Ther 1:516\u2013521. https:\/\/doi.org\/10.1006\/mthe.2000.0083","journal-title":"Mol Ther"},{"key":"2224_CR47","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/B978-0-12-800563-7.00015-4","volume-title":"Translating gene therapy to the clinic","author":"SB Mueller","year":"2015","unstructured":"Mueller SB, Kontos CD (2015) Translating gene therapy to the clinic. In: Laurence J, Franklin M (eds) Translating gene therapy to the clinic. Academic Press, pp 227\u2013246"},{"key":"2224_CR48","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s10020-023-00680-z","volume":"29","author":"J Gong","year":"2023","unstructured":"Gong J, Yang R, Zhou M, Chang L-J (2023) Improved intravenous lentiviral gene therapy based on endothelial-specific promoter-driven factor VIII expression for hemophilia A. Mol Med 29:74. https:\/\/doi.org\/10.1186\/s10020-023-00680-z","journal-title":"Mol Med"},{"key":"2224_CR49","doi-asserted-by":"publisher","first-page":"571","DOI":"10.3390\/pathogens13070571","volume":"13","author":"CJ de Vos","year":"2024","unstructured":"de Vos CJ, Elbers ARW (2024) Quantitative risk assessment of wind-supported transmission of Highly Pathogenic Avian Influenza Virus to Dutch poultry farms via fecal particles from infected wild birds in the environment. Pathogens 13:571","journal-title":"Pathogens"},{"key":"2224_CR50","doi-asserted-by":"publisher","first-page":"44775","DOI":"10.1038\/srep44775","volume":"7","author":"JR Counsell","year":"2017","unstructured":"Counsell JR et al (2017) Lentiviral vectors can be used for full-length dystrophin gene therapy. Sci Rep 7:44775. https:\/\/doi.org\/10.1038\/srep44775","journal-title":"Sci Rep"},{"key":"2224_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/v12091016","author":"A Gutierrez-Guerrero","year":"2020","unstructured":"Gutierrez-Guerrero A, Cosset FL, Verhoeyen E (2020) Lentiviral vector pseudotypes: precious tools to improve gene modification of hematopoietic cells for research and gene therapy. Viruses. https:\/\/doi.org\/10.3390\/v12091016","journal-title":"Viruses"},{"key":"2224_CR52","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jneumeth.2010.03.019","volume":"189","author":"M Li","year":"2010","unstructured":"Li M et al (2010) Optimal promoter usage for lentiviral vector-mediated transduction of cultured central nervous system cells. J Neurosci Methods 189:56\u201364. https:\/\/doi.org\/10.1016\/j.jneumeth.2010.03.019","journal-title":"J Neurosci Methods"},{"key":"2224_CR53","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.gene.2012.01.071","volume":"498","author":"SC Ngai","year":"2012","unstructured":"Ngai SC, Rosli R, Nordin N, Veerakumarasivam A, Abdullah S (2012) Lentivirus vector driven by polybiquitin C promoter without woodchuck posttranscriptional regulatory element and central polypurine tract generates low level and short-lived reporter gene expression. Gene 498:231\u2013236. https:\/\/doi.org\/10.1016\/j.gene.2012.01.071","journal-title":"Gene"},{"key":"2224_CR54","doi-asserted-by":"publisher","first-page":"19265","DOI":"10.1038\/s41598-021-98657-7","volume":"11","author":"V Kalidasan","year":"2021","unstructured":"Kalidasan V et al (2021) A guide in lentiviral vector production for hard-to-transfect cells, using cardiac-derived c-kit expressing cells as a model system. Sci Rep 11:19265. https:\/\/doi.org\/10.1038\/s41598-021-98657-7","journal-title":"Sci Rep"},{"key":"2224_CR55","doi-asserted-by":"publisher","first-page":"102032","DOI":"10.1016\/j.xpro.2022.102032","volume":"4","author":"W Ji","year":"2023","unstructured":"Ji W, Zhang L, Liu X (2023) Protocol using lentivirus to establish THP-1 suspension cell lines for immunostaining and confocal microscopy. STAR Protoc 4:102032. https:\/\/doi.org\/10.1016\/j.xpro.2022.102032","journal-title":"STAR Protoc"},{"key":"2224_CR56","doi-asserted-by":"publisher","first-page":"102903","DOI":"10.1016\/j.xpro.2024.102903","volume":"5","author":"E Navarro-Guerrero","year":"2024","unstructured":"Navarro-Guerrero E, Baronio R, Tay C, Knight JC, Ebner DV (2024) Optimized protocol for CRISPR knockout of human iPSC-derived macrophages. STAR Protoc 5:102903. https:\/\/doi.org\/10.1016\/j.xpro.2024.102903","journal-title":"STAR Protoc"},{"key":"2224_CR57","doi-asserted-by":"publisher","first-page":"11815","DOI":"10.1073\/pnas.0404508101","volume":"101","author":"B Lupiani","year":"2004","unstructured":"Lupiani B et al (2004) Marek\u2019s disease virus-encoded Meq gene is involved in transformation of lymphocytes but is dispensable for replication. Proc Natl Acad Sci U S A 101:11815\u201311820. https:\/\/doi.org\/10.1073\/pnas.0404508101","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2224_CR58","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00892-20","author":"Y Liao","year":"2020","unstructured":"Liao Y et al (2020) Role of Marek\u2019s Disease Virus (MDV)-encoded U(S)3 serine\/threonine protein kinase in regulating MDV Meq and cellular CREB phosphorylation. J Virol. https:\/\/doi.org\/10.1128\/jvi.00892-20","journal-title":"J Virol"},{"key":"2224_CR59","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.virol.2015.06.012","volume":"484","author":"KW Jarosinski","year":"2015","unstructured":"Jarosinski KW, Vautherot J-F (2015) Differential expression of Marek\u2019s disease virus (MDV) late proteins during in vitro and in situ replication: Role for pUL47 in regulation of the MDV UL46\u2013UL49 gene locus. Virology 484:213\u2013226. https:\/\/doi.org\/10.1016\/j.virol.2015.06.012","journal-title":"Virology"}],"container-title":["Virus Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11262-026-02224-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11262-026-02224-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11262-026-02224-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T09:26:49Z","timestamp":1780306009000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11262-026-02224-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,27]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["2224"],"URL":"https:\/\/doi.org\/10.1007\/s11262-026-02224-z","relation":{},"ISSN":["0920-8569","1572-994X"],"issn-type":[{"value":"0920-8569","type":"print"},{"value":"1572-994X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,27]]},"assertion":[{"value":"7 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article. Mention of trade names or commercial products in this publication is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the U.S. Department of Agriculture.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}